SLN360
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for SLN360, covering 2024-08-12 to 2025-07-01. Get the full timeline:
Most recent: Clinical Trial Update: Evaluate SLN360 in Participants With Elevated Lipoprotein(a) at High Risk of Atherosclerotic Cardiovascular Disease Events [Phase 2]